Peter Libby

6.6k total citations · 1 hit paper
41 papers, 5.1k citations indexed

About

Peter Libby is a scholar working on Surgery, Immunology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Peter Libby has authored 41 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 12 papers in Immunology and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Peter Libby's work include Atherosclerosis and Cardiovascular Diseases (10 papers), Lipoproteins and Cardiovascular Health (9 papers) and Protease and Inhibitor Mechanisms (6 papers). Peter Libby is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (10 papers), Lipoproteins and Cardiovascular Health (9 papers) and Protease and Inhibitor Mechanisms (6 papers). Peter Libby collaborates with scholars based in United States, United Kingdom and Japan. Peter Libby's co-authors include Galina K. Sukhova, Zorina S. Galis, Michael W. Lark, Justin C. Mason, Stephen J. Warner, Edi Brogi, C. T. Dollery, Daniel R. Schwartz, K R Auger and Steven K. Clinton and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

Peter Libby

34 papers receiving 4.9k citations

Hit Papers

Increased expression of matrix metalloproteinases and mat... 1994 2026 2004 2015 1994 500 1000 1.5k 2.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Libby United States 22 1.5k 1.4k 1.4k 1.2k 1.1k 41 5.1k
Kevin Croce United States 37 1.9k 1.2× 813 0.6× 1.1k 0.8× 2.4k 2.0× 1.1k 1.0× 100 6.0k
Yutaka Nakashima Japan 38 1.4k 0.9× 976 0.7× 1.6k 1.2× 2.0k 1.7× 955 0.8× 124 6.7k
David H. Lovett United States 50 1.0k 0.7× 1.8k 1.3× 811 0.6× 2.5k 2.1× 784 0.7× 126 6.6k
Margreet R. de Vries Netherlands 39 1.3k 0.9× 807 0.6× 1.2k 0.9× 1.9k 1.6× 654 0.6× 146 4.5k
Katsuo Sueishi Japan 47 809 0.5× 775 0.5× 1.6k 1.2× 2.7k 2.2× 1.2k 1.0× 203 7.5k
T. Kooistra Netherlands 38 662 0.4× 1.4k 1.0× 928 0.7× 1.2k 1.0× 454 0.4× 74 4.7k
M A Gimbrone United States 29 1.6k 1.1× 567 0.4× 879 0.6× 2.5k 2.1× 1.3k 1.1× 37 6.8k
Akira Ooshima Japan 49 781 0.5× 952 0.7× 1.3k 0.9× 3.9k 3.3× 612 0.5× 240 9.5k
Robin N. Poston United Kingdom 35 1.7k 1.1× 512 0.4× 675 0.5× 1.1k 1.0× 453 0.4× 91 4.9k
Ewa Paleolog United Kingdom 46 1.5k 1.0× 989 0.7× 725 0.5× 2.3k 1.9× 334 0.3× 123 6.6k

Countries citing papers authored by Peter Libby

Since Specialization
Citations

This map shows the geographic impact of Peter Libby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Libby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Libby more than expected).

Fields of papers citing papers by Peter Libby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Libby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Libby. The network helps show where Peter Libby may publish in the future.

Co-authorship network of co-authors of Peter Libby

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Libby. A scholar is included among the top collaborators of Peter Libby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Libby. Peter Libby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fogacci, Federica, Peter Libby, & Arrigo F.G. Cicero. (2025). Lipoprotein(a)—To test or not to test, not a dilemma but a mandate. Journal of clinical lipidology. 19(6). 1520–1522.
2.
Flynn, Spencer, Art Schuermans, Md Mesbah Uddin, et al.. (2025). Clonal Hematopoiesis and Incident Heart Failure. JAMA Cardiology. 11(2). 126–126.
4.
Mason, Justin C. & Peter Libby. (2014). Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. European Heart Journal. 36(8). 482–489. 293 indexed citations
5.
Shimizu, Kazuo, Peter Libby, & Ralph Mitchell. (2005). Local Cytokine Environments Drive Aneurysm Formation in Allografted Aortas. Trends in Cardiovascular Medicine. 15(4). 142–148. 23 indexed citations
6.
Dollery, C. T. & Peter Libby. (2005). Atherosclerosis and proteinase activation. Cardiovascular Research. 69(3). 625–635. 193 indexed citations
7.
Arboleda‐Velásquez, Joseph F., Raajit K. Rampal, Erik Fung, et al.. (2005). CADASIL mutations impair Notch3 glycosylation by Fringe. Human Molecular Genetics. 14(12). 1631–1639. 47 indexed citations
8.
Libby, Peter & P.J. Skerrett. (2005). Searching for hidden heart risks.. PubMed. 146(14). 73–4.
9.
Bonow, Robert O., Douglas P. Zipes, Peter Libby, Bonow Ro, & Eugene Braunwald. (2004). Heart Disease: A Textbook of Cardiovascular Medicine. 7th Edition. 203 indexed citations
10.
Rifai, Nader, et al.. (2002). Effect of atorvastatin on C-reactive protein in patients with acute coronary syndromes: a substudy of the MIRACL trial. Journal of the American College of Cardiology. 39. 304–304. 10 indexed citations
11.
Byrne, Gerald I., Carl Grünfeld, Murat V. Kalayoglu, et al.. (2000). Collaborative Multidisciplinary Workshop Report: Interface of Lipid Metabolism, Atherosclerosis, andChlamydiaInfection. The Journal of Infectious Diseases. 181(s3). S490–S491. 7 indexed citations
12.
Libby, Peter, Masanori Aikawa, Scott Kinlay, Andrew P. Selwyn, & Peter Ganz. (2000). Lipid lowering improves endothelial functions. International Journal of Cardiology. 74. S3–S10. 32 indexed citations
13.
Kol, Amir & Peter Libby. (1999). Molecular mediators of arterial inflammation: A role for microbial products?. American Heart Journal. 138(5). S450–S452. 30 indexed citations
14.
Mach, François, Uwe Schönbeck, & Peter Libby. (1998). CD40 signaling in vascular cells: A key role in atherosclerosis?. Atherosclerosis. 137. S89–S95. 147 indexed citations
15.
Libby, Peter & H. Tanaka. (1997). The molecular bases of restenosis. Progress in Cardiovascular Diseases. 40(2). 97–106. 104 indexed citations
16.
Libby, Peter & Hiroyuki Tanaka. (1994). The pathogenesis of coronary arteriosclerosis (“chronic rejection”) in transplanted hearts. Clinical Transplantation. 8(3pt2). 313–318. 73 indexed citations
17.
Winkles, Jeffrey A., Gregory F. Alberts, Edi Brogi, & Peter Libby. (1993). Endothelin-1 and Endothelin Receptor mRNA Expression in Normal and Atherosclerotic Human Arteries. Biochemical and Biophysical Research Communications. 191(3). 1081–1088. 186 indexed citations
18.
Libby, Peter, Scott J. Swanson, Hideo Tanaka, et al.. (1992). Immunopathology of coronary arteriosclerosis in transplanted hearts.. PubMed. 11(3 Pt 2). S5–6. 25 indexed citations
19.
Libby, Peter, Daniel R. Schwartz, Edi Brogi, Hiroyuki Tanaka, & Steven K. Clinton. (1992). A cascade model for restenosis. A special case of atherosclerosis progression.. PubMed. 86(6 Suppl). III47–52. 384 indexed citations
20.
Libby, Peter. (1989). The functions of blood vessel wall cells in atherogenesis and coronary artery disease.. PubMed. 53(2). 71–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026